相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The potential role of estrogen receptor β2 in breast cancer
Jong-Min Baek et al.
INTERNATIONAL JOURNAL OF SURGERY (2015)
Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer
K. Hashimoto et al.
ANNALS OF ONCOLOGY (2014)
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer
A. M. Gonzalez-Angulo et al.
ANNALS OF ONCOLOGY (2014)
Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer
Fadia J. A. Gujam et al.
BMC CANCER (2014)
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
Jordan M. Reese et al.
BMC CANCER (2014)
ERβ splice variant expression in four large cohorts of human breast cancer patient tumors
Hallie Wimberly et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Targeting Akt3 Signaling in Triple-Negative Breast Cancer
Y. Rebecca Chin et al.
CANCER RESEARCH (2014)
Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer
Joyce O'Shaughnessy et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Co-expression of EGFR and CK5/6 in primary squamous cell carcinoma of the breast
Jin Wang et al.
MEDICAL ONCOLOGY (2014)
Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
Bo Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)
Y. Yan et al.
ANNALS OF ONCOLOGY (2013)
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
Marcelo Madeira et al.
BMC CANCER (2013)
Wnt signaling in triple negative breast cancer is associated with metastasis
Nandini Dey et al.
BMC CANCER (2013)
Research Resource: Global Identification of Estrogen Receptor β Target Genes in Triple Negative Breast Cancer Cells
Erin K. Shanle et al.
MOLECULAR ENDOCRINOLOGY (2013)
Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR
Daniela A. Ferraro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: A meta-analysis
Jin Wang et al.
SURGICAL ONCOLOGY-OXFORD (2013)
Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
Johanna C. Bendell et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
Lisa A. Carey et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
S. Samanta et al.
ONCOGENE (2012)
ER beta 1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
Christoforos Thomas et al.
BREAST CANCER RESEARCH (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers
Max Yan et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases
Barbara Adamo et al.
BREAST CANCER RESEARCH (2011)
The different roles of ER subtypes in cancer biology and therapy
Christoforos Thomas et al.
NATURE REVIEWS CANCER (2011)
Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Jonathan D. Marotti et al.
MODERN PATHOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immunohistochemical Detection of Phospho-Akt, Phospho-BAD, HER2 and Oestrogen Receptors alpha and beta in Malaysian Breast Cancer Patients
Heng Fong Seow et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Nuclear and cytoplasmic expression of ERβ1, ERβ2, and ERβ5 identifies distinct prognostic outcome for breast cancer patients
Abeer M. Shaaban et al.
CLINICAL CANCER RESEARCH (2008)
Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy
Naoko Honma et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study
Flavia Novelli et al.
BREAST CANCER RESEARCH (2008)
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
Berengere Marty et al.
BREAST CANCER RESEARCH (2008)
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer
R. L. Dillon et al.
ONCOGENE (2007)
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
Sofia K. Gruvberger-Saal et al.
CLINICAL CANCER RESEARCH (2007)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Lisa M. McShane et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells
Edmund C. Chang et al.
ENDOCRINOLOGY (2006)
Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
G. P. Skliris et al.
BRITISH JOURNAL OF CANCER (2006)
AKT regulation of estrogen receptor β transcriptional activity in breast cancer
Bich N. Duong et al.
CANCER RESEARCH (2006)
Estrogen receptor (ER)-β isoforms:: A key to understanding ER-β signaling
Yuet-Kin Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Oestrogen receptor β and neoadjuvant therapy with tamoxifen:: prediction of response and effects of treatment
WR Miller et al.
BRITISH JOURNAL OF CANCER (2006)
Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor β but not the estrogen receptor αgene
HG Chang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Estrogen receptor β (ERβ) level but not its ERβcx variant helps to predict tamoxifen resistance in breast cancer
M Esslimani-Sahla et al.
CLINICAL CANCER RESEARCH (2004)
Estrogen receptor β in prostate cancer
O Imamov et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
ERβ exerts multiple stimulative effects on human breast carcinoma cells
YF Hou et al.
ONCOGENE (2004)
Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue
GP Skliris et al.
JOURNAL OF PATHOLOGY (2002)
Estrogen receptors and proliferation markers in primary and recurrent breast cancer
EV Jensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
